Author

G. Kobinger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:human· 2 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

D. Kobasa· 2 shared A. Beauchemin· 1 shared A. Singh· 1 shared C. Letanneur· 1 shared C. M. Stewart· 1 shared G. Elfayres· 1 shared G. Laroche· 1 shared H. Azizi· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. Kobasa

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles

G. Elfayres, R. R. Paswan, L. Sika, M.-P. Girard, S. Khalfi, C. Letanneur, K. Milette, A. Singh, G. Kobinger, L. Berthoux

This paper develops a platform for generating SARS-CoV-2 virus-like particles (VLPs) using mammalian cells, showing that co-expression of four structural proteins enables efficient VLP production and stable cell lines for vaccine development.

bioRxiv · Jul 24, 2023Microbiology

Sphingosine kinases promote Ebola virus infection and can be targeted to inhibit filoviruses, coronaviruses, and arenaviruses using late endocytic trafficking to enter cells

C. M. Stewart, Y. Bo, K. Fu, M. Chan, R. Kozak, K. Y.-P. Apperley, G. Laroche, A. Beauchemin, G. Kobinger, D. Kobasa, M. Cote

This study shows that sphingosine kinases (SKs) facilitate entry of late-penetrating viruses like Ebola and SARS-CoV-2 by promoting endocytic trafficking, and their inhibition blocks viral entry.

bioRxiv · Aug 12, 2022Microbiology

Development and characterization of influenza M2 ectodomain and/or HA stalk-based DC-targeting vaccines for different influenza infections

X. Yao, T. Olukitibi, Z. Ao, H. Azizi, M. Mahmoudi, K. Coombs, D. Kobasa, G. Kobinger

This study develops and tests DC-targeting influenza vaccines based on EboGP domains, showing they induce strong antibody responses and protect mice against H1N1 and H3N2 influenza.

bioRxiv · Oct 7, 2021 · PreprintMicrobiology